Pharmafile Logo
Pharmafocus logo
Advanced Search

Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium

January 19, 2023
Business Services

PARIS, France, and PRINCETON, N.J., January 19, 2023 – Servier and Taiho Oncology, Inc., today announced the release of data …

News
Press release

NeoPhore completes extension to Series B financing to further advance discovery pipeline

January 19, 2023
Business Services

Cambridge, UK, 19 January 2023 – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the completion of its £21.5m …

News
Press release

AI tool to improve blood sugar management in type 1 diabetes patients

January 18, 2023
Medical Communications

A new app, designed by researchers at Oregon Health & Science University (OSHU), uses artificial intelligence (AI) to assess blood …

News

Neuronetics Inc. announces efficacy of treatment for neurohealth disorders

January 18, 2023
Research and Development

US-based commercial-stage medical technology company Neuronetics Inc., which focuses on designing, developing and marketing products that improve the quality of …

News

Shockwave Medical acquires Neovasc for $100m

January 18, 2023
Research and Development

US-based cardiovascular medical device company Shockwave Medical has signed a deal to acquire specialty medical device company Neovasc for around …

News

Cambridge’s Experimental Cancer Medicine Centre to receive funding for clinical trials

January 18, 2023
Medical Communications

The Experimental Cancer Medicine Centre (ECMC) in Cambridge is one of a selection of organisations to receive a share of …

News

PFIZER EXPANDS ‘AN ACCORD FOR A HEALTHIER WORLD’ PRODUCT OFFERING TO INCLUDE FULL PORTFOLIO FOR GREATER BENEFIT TO 1.2 BILLION PEOPLE IN 45 LOWER-INCOME COUNTRIES

January 18, 2023
Business Services

DAVOS, Switzerland, January 17, 2023 – Pfizer Inc.

News
Press release

UCL to begin new trial to assess cough medicine’s impact on Parkinson’s disease

January 17, 2023
Medical Communications

Researchers led by a team at University College London (UCL) have began researching the impacts of ambroxol, a common ingredient …

News

Johnson & Johnson scale back COVID-19 vaccination production

January 17, 2023
Manufacturing and Production

US-based Johnson & Johnson (J&J) have begun scaling back production of their COVID-19 vaccine due to demand falling over the …

News

Thermo Fisher to become founding sponsor of Momentum Labs

January 17, 2023
Medical Communications

Thermo Fisher Scientific has announced that it has become a founding sponsor of Momentum Labs in Alachua, Florida, US. The …

News

Indonesia begins hearing class-action lawsuit after children’s deaths from cough syrup

January 17, 2023
Medical Communications

An Indonesian court has begun proceedings to hear a class-action lawsuit against health and finance ministries, the drugs regulator and …

News

Green Bioactives appoints experienced biotech leaders Chris Meaney and Andy Hall-Ponselé to expand senior management team

January 17, 2023
Business Services

Edinburgh, Scotland, 17 January 2023 – Green Bioactives Limited (‘GBL’), a world-leader in the discovery, development and sustainable production of …

Appointment

AstraZeneca UK, Qure.ai and Greater Manchester Cancer Alliance Join Forces to Battle Lung Cancer Waiting Times Using Artificial Intelligence (AI) Technology

January 17, 2023
Business Services

London, UK, 13 January 2023 – An initiative to improve earlier diagnosis of lung cancer has been launched by AstraZeneca UK, …

News
Press release

The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations

January 16, 2023
Business Services

16 January 2023, Feltham (Merck) – Today Merck, a leading science and technology company, announced that following a resubmission to …

News
Press release

Boehringer Ingelheim and 3T Biosciences form $268m partnership to develop next-generation cancer immunotherapies

January 16, 2023
Medical Communications

Germany-based Boehringer Ingelheim and US company 3T Biosciences have entered into a strategic collaboration and licensing agreement to research and …

News

Eli Lilly and AbbVie leave UK VPAS; blow to UK pharma industry

January 16, 2023
Medical Communications

Eli Lilly and AbbVie have announced their departure from the voluntary scheme for branded medicines pricing and access (VPAS), causing …

News

Luye Pharma’s Rykindo® approved by FDA for treatment of schizophrenia and bipolar 1 disorder

January 16, 2023
Research and Development

International pharmaceutical company, Luye Pharma, has announced that Rykindo® has received FDA approval for the treatment of schizophrenia in adult …

News

AstraZeneca’s Tezspire gains CHMP approval for the treatment of severe asthma

January 16, 2023
Research and Development

AstraZeneca has announced that Tezspire (also known as tezepelumab) has received approval from the EMA’s Committee for Medicinal Products for …

News

Poolbeg announces strategic expansion of POLB 001 into oncology

January 16, 2023
Business Services

16 January 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …

News
Press release

finnCap Cavendish advises on the sale of MBI Healthcare Technologies to DNV

January 13, 2023
Business Services

London, 9th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised the three …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025